Source notes

A test for food allergy driven by IgE, an allergy-related antibody, needs a clear clinical question. The panel starts with the reaction history, then selects tests for suspected foods. Its pooled diagnostic evidence illustrates both the value and limits of testing. Across the included age groups, cashew skin-prick testing identified about 93% of allergic participants and correctly classified about 92% of nonallergic participants. These estimates came from studies using different cutoffs, not a universal screening rule. Performance varied by food. When the history and tests leave uncertainty, a medically supervised food challenge remains the reference method for resolving it.

Those percentages do not mean that a positive result gives any individual a 93% chance of allergy. That probability also depends on how likely allergy was before testing. These antibodies can recognize a food without symptoms occurring when it is eaten. Conversely, a convincing reaction history should not be dismissed solely because an initial test is negative.

How Does This Show Up in Real Life?

Suppose an extensive test panel flags a food that you regularly eat without symptoms. The useful next step is to ask how that result fits your actual experience, rather than automatically removing every flagged food. The panel advises selecting tests from the history and avoiding indiscriminate testing. It also recommends against using IgG tests, a different antibody test often marketed for food reactions, to diagnose this kind of allergy. A clinician may use more targeted tests when pollen cross-reactions or conflicting results complicate the picture. For a child with an established allergy, reassessment can determine whether it has resolved. This is not permission to test a previously troublesome food at home; a supervised challenge may still be necessary.

Much of the evidence behind diagnostic cutoffs comes from children, with fewer studies in adults and uneven coverage across foods and regions. A threshold validated in one setting may not work equally well elsewhere. The panel also found no controlled evidence establishing the best reassessment frequency. Follow-up decisions therefore depend on age, the particular food, and the reaction history.

Why We Cite It

For Alpekin, this offers a data-handling lesson: results from different testing methods are not automatically interchangeable. A nutrition record could preserve the test method, clinical interpretation, and reassessment status rather than retaining an unexplained positive label. That would support clearer communication with qualified clinicians without turning food-planning software into a diagnostic service.

The strongest takeaway is about interpretation, not collecting more results. Useful testing narrows uncertainty in a specific person. A longer list of positive findings is not necessarily a better diagnosis, and a laboratory number should not become a lifelong food rule without clinical context.